Houston, TX, February 9, 2012 – OrthoAccel Technologies, Inc., developers of the AcceleDent™ System, which is an acceleration device to enhance orthodontics, announced a new Vice President of Professional Relations this week: Art Basehart. Mr. Basehart began effective February 1, 2012 and is overseeing the key accounts and strategic relationships function at OrthoAccel.
AcceleDent is a simple, removable and non-invasive device that a patient uses with braces in the mouth for 20 minutes daily to accelerate orthodontic tooth movement. The Company announced FDA clearance late last year. A randomized, controlled clinical trial conducted at the University of Texas Health Science Center at San Antonio demonstrated, with statistical significance, that tooth movement could be accelerated by 106% during the alignment phase and by 38% to 50% during space closure. There was no evidence of incremental root resorption or adverse events, thus demonstrating an excellent safety profile for the appliance.
Mr. Basehart joins OrthoAccel as it carries out its launch of the AcceleDent System into the US market, bringing 28 years of industry experience to the OrthoAccel team. His background includes 26 years with a market leader orthodontics business of the dental division of a Fortune 100 company. The past 2 years have been spent with a privately owned, rapidly growing orthodontic company. His highlight assignment there involved the North American launch of an innovative new customized lingual treatment system.
“Art’s extensive experience in sales, key account management, marketing, training, and industry relations within the dental industry will serve us well as we drive to build relationships within academia and key thought leaders within the dental industry,” commented Mike Lowe, CEO at OrthoAccel.
Last month, the Company reported significant interest around its AcceleDent System at the joint American Association of Orthodontists & American Academy of Pediatric Dentistry 2012 Mid-Winter Meeting held in Marco Island, Florida.
Mr. Basehart remarked, “I am delighted to be joining the OrthoAccel team. I believe that the value proposition that the AcceleDent System delivers will positively impact the orthodontist as well as the patients they treat. During my career in the orthodontic industry, I have seen several key innovations that have dramatically improved efficiency and effectiveness. AcceleDent is in that category.”
OrthoAccel has also announced its plans to exhibit at the 112th Annual Session of the American Association of Orthodontists in Honolulu, Hawaii, to be held May 4 – 8, 2012.
About OrthoAccel® Technologies, Inc.
Based in Houston, Texas, OrthoAccel® Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.
About the AcceleDent™ System
AcceleDent™ represents the first clinical approach to accelerate orthodontic tooth movement via modulating bone biology. The appliance has been studied clinically as a complement to standard orthodontic appliances to apply gentle pulsing forces to the dentition to move teeth faster through accelerated bone remodeling. More information can be found at www.acceledent.com or requested via firstname.lastname@example.org
Media Contact Michael K. Lowe, CEO +1 (832) 631-1659